BRIEF-CRISPR Therapeutics appoints Michael Tomsicek as CFO
November 13, 2017 at 08:12 AM EST
* CRISPR Therapeutics announces appointment of Michael Tomsicek as Chief Financial Officer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.